yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
MDT276
MDT276
http://dx.doi.org/10.1093/ANNONC/MDT276
First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: pooled and subgroup analyses of data from 2447 patients.
P356
Q30657829-952356F7-9E00-4980-993F-CD6173A22AC0
P356
MDT276
http://dx.doi.org/10.1093/ANNONC/MDT276